🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So great to have FDA Commisioner Califf join our biotech community in SF this weekend

Reserve your spot to network and engage in compelling discussions with biotech and pharma CEOs, R&D leaders, BD heads and investors at #MiamiCEO in Key Biscayne longwoodhealthcareleaders.com/miamiceo

Thank you for seeking to help the patients in need of better alternatives

We were honored to host cross industry stakeholders at #SanFranciso immediately prior to #JPM. See the 3 minute event recap with interviews featuring Jay Bradner, M.D. Levi A. Garraway Dr. Stephen M. Hahn Jeremy Levin, Marianne De Backer, MSc, PhD, MBA Mathai Mammen Julie Gerberding and others: longwoodhealthcareleaders.com/gallery

We had over 150 great biopharma leaders at our longwood office for cocktails and to celebrate the Celtics (Ray from novo is a warriors fan boo :) )

It has been our honor to host amazing female leaders across the life sciences, academia & government at #LongwoodHealthcareLeaders meetings, where approximately 1/3 of speakers are female. Join us in 2025 where we look forward to growing that number! #IWD #InternationalWomensDay

Co-hosted with Massachusetts Institute of Technology (MIT) President Sally Kornbluth, Phil Sharp (co-founder Biogen/Alnylam), Bob Langer (co-founder Moderna), MIT CEO brings together leaders in the industry for off-the-record discussions in the heart of Cambridge’s Kendall Square. conta.cc/4kK0d7V

Go ALNY!

We are honored that FDA CBER Director Peter Marks and Biotechnology Innovation Organization John Crowley will join the conversation at #MiamiCEO with leaders from biotech and pharma. See the agenda: longwoodhealthcareleaders.com/miamiceo

Ran into some Boston legends

Potentially a new class of medicines to help patients in need

We are honored to be joined by world-class pharma and biotech leaders at the 3rd annual #MiamiCEO at The Ritz-Carlton Key Biscayne. We look forward to important discussions in the coming days during this pivotal time to come together.

We had a terrific time hosting #biotech and #pharma CEOs and industry leaders at last week’s #MiamiCEO. We are grateful for the candid insights shared by participants and for the invaluable networking. Our photo gallery is online, feel free to share! longwoodhealthcareleaders.com/past-events/mi…

A wonderful dinner w my dear old friend and lab benchmate Alnylam Pharmaceuticals head of R Kevin Fitzgerald. Originator of all 6 approved ALNY drugs.

LEQVIO growing and approaching blockbuster status with ⁦Novartis⁩! With AMVUTTRA, there will be two $B RNAi therapeutics be end 2025!

So great to be at MIT every year

Our next guest (Ep.19) on BioVenture VoiCes will be legendary Christoph Westphal, Co-founder and General Partner of Longwood Fund. He describes his journey from his Harvard MD-PhD to early experiences at Polaris Partners and GSK/SR One building successful biotech companies (incl. Alnylam Pharmaceuticals)

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: Longwood Fund's Christoph Westphal on founding companies, venture investing, the current environment in biotech, and his love of the Boston ecosystem. Full video: biotechtv.com/post/bioventur…

Fun speaking at MIT today at the great ABI conference